HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,544,982 | -1.5% | 17,247 | -6.3% | 0.06% | +3.2% |
| Q2 2023 | $1,568,000 | +3.0% | 18,416 | +0.1% | 0.06% | +1.6% |
| Q1 2023 | $1,523,000 | +2.7% | 18,402 | -2.4% | 0.06% | +7.0% |
| Q4 2022 | $1,483,000 | +122.7% | 18,859 | +225.2% | 0.06% | +171.4% |
| Q4 2019 | $666,000 | -9.0% | 5,800 | 0.0% | 0.02% | -12.5% |
| Q3 2019 | $732,000 | -15.5% | 5,800 | -19.4% | 0.02% | -14.3% |
| Q2 2019 | $866,000 | +37.5% | 7,200 | 0.0% | 0.03% | +40.0% |
| Q1 2019 | $630,000 | -7.4% | 7,200 | +5.9% | 0.02% | -13.0% |
| Q4 2018 | $680,000 | -12.7% | 6,800 | 0.0% | 0.02% | +4.5% |
| Q3 2018 | $779,000 | +27.7% | 6,800 | 0.0% | 0.02% | -21.4% |
| Q2 2018 | $610,000 | -12.2% | 6,800 | -28.4% | 0.03% | -9.7% |
| Q1 2018 | $695,000 | -19.7% | 9,500 | -36.2% | 0.03% | -13.9% |
| Q4 2017 | $865,000 | – | 14,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |